B. Dimension EXL System Enzymatic Creatinine (EZCR) Assay
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
10471520
19035AA
A. Dimension Vista System Enzymatic Creatinine Assay (ECREA)
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
K1270A
Introduction
Affected Products
A. Dimension Vista System Enzymatic Creatinine Assay (ECREA)
B. Dimension EXL System Enzymatic Creatinine (EZCR) Assay
Reason
Siemens healthcare diagnostics has become aware that the presence of n-acetyl-p-benzoquinone imine (NAPQI), a metabolite of acetaminophen, may cause interference in certain chemistry assays when testing patient samples. This interference may cause falsely depressed fructosamine and creatinine results in patient samples.
Currently, the "limitations of the procedure" sections in the affected assay instructions for use (IFU) do not indicated that NAPQI is a metabolite of acetaminophen and that certain concentrations of NAPQI (NAPQI concentrations specific to each affected assay) may lead to falsely depressed results for patient samples. The "limitations of the procedure" sections also do not state that the use of the assay is not recommended for patients being treated for an overdose of acetaminophen.